These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16447136)

  • 21. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
    van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA
    Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
    Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
    Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    van der Harst S
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1853-4; author reply 1854. PubMed ID: 17874645
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
    Prymula R; Chlibek R; Splino M; Kaliskova E; Kohl I; Lommel P; Schuerman L
    Vaccine; 2008 Aug; 26(35):4563-70. PubMed ID: 18602724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine.
    Abuelreish M; Subedar A; Chiu T; Wludyka P; Rathore M
    Clin Pediatr (Phila); 2007 Jan; 46(1):45-52. PubMed ID: 17164509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seven-valent pneumococcal conjugate vaccines for developing countries.
    Obaro S
    Expert Rev Vaccines; 2009 Aug; 8(8):1051-61. PubMed ID: 19627187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives.
    Bechini A; Boccalini S; Bonanni P
    Vaccine; 2009 May; 27(25-26):3285-90. PubMed ID: 19200829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages.
    Daley MF; Crane LA; Beaty BL; Barrow J; Pearson K; Stevenson JM; Berman S; Kempe A
    Ambul Pediatr; 2005; 5(3):157-64. PubMed ID: 15913409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness studies of pneumococcal conjugate vaccines.
    McIntosh ED
    Expert Rev Vaccines; 2004 Aug; 3(4):433-42. PubMed ID: 15270648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cincinnati pediatricians' measured and reported immunizing behavior for children during the national shortages of pneumococcal conjugate vaccine.
    Fairbrother G; Donauer S; Staat MA; Broder K; Salisbury S; Morrow AL; Tabangin ME; Altaye M; Holloway M; Schwartz B
    Vaccine; 2013 Apr; 31(17):2177-83. PubMed ID: 23474316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
    Pletz MW; Maus U; Hohlfeld JM; Lode H; Welte T
    Dtsch Med Wochenschr; 2008 Feb; 133(8):358-62. PubMed ID: 18270917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar) since vaccine introduction.
    Center KJ; Strauss A
    Vaccine; 2009 May; 27(25-26):3281-4. PubMed ID: 19200818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels].
    Salleras L; Domínguez A; Ciruela P; Izquierdo C; Borràs E;
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):275-7. PubMed ID: 19386393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of otitis media: now a reality?
    Schuerman L; Borys D; Hoet B; Forsgren A; Prymula R
    Vaccine; 2009 Sep; 27(42):5748-54. PubMed ID: 19666154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.
    Dinleyici EC; Yargic ZA
    Expert Rev Vaccines; 2009 Aug; 8(8):977-86. PubMed ID: 19627181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.